亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。

返回搜索結果

Method to Predict Treatment Response in Generalized Social Phobia

詳細技術說明

Inventors at UC San Diego have patented a method for optimizing therapeutic efficacy of treatment in a subject diagnosed with generalized social anxiety disorder. The method includes determining a subject's serotonin transporter gene promoter polymorphism genotype, correlating the subject's serotonin transporter gene promoter polymorphism genotype with a probability of being a positive responder or poor responder to therapy with a serotonin reuptake inhibitor, and selecting a drug for treatment based on the correlation. The method will assist physicians in making treatment decisions for individual patients with the disorder.

附加資料

Patent Number: US8026059B2
Application Number: US2008279178A
Inventor: Stein, Murray B. | Gelernter, Joel
Priority Date: 15 Feb 2006
Priority Number: US8026059B2
Application Date: 22 Apr 2009
Publication Date: 27 Sep 2011
IPC Current: C12Q000168
US Class: 43500611 | 435006
Assignee Applicant: The Regents of the University of California
Title: Treatment response in generalized social phobia
Usefulness: Treatment response in generalized social phobia
Summary: The methods are useful for determining a response profile to treatment with a SRI in a subject diagnosed with generalized social anxiety disorder, determining whether to treat or continue treatment of a subject diagnosed with generalized social anxiety disorder with a serotonin reuptake inhibitor, and optimizing therapeutic efficacy of treatment in a subject diagnosed with generalized social anxiety disorder.
Novelty: Determining response profile to treatment with serotonin reuptake inhibitor (SRI) in a subject diagnosed with generalized social anxiety disorder by determining the subject's serotonin transporter gene promoter polymorphism genotype